The diagnostic and prognostic value of tau‐PET in amnestic MCI with different FDG‐PET subtypes

Abstract Objectives Mild cognitive impairment presenting with an amnestic syndrome (aMCI) and amyloid positivity is considered due to AD. Many subjects, however, can show an overall very slow progression relevant for differential diagnosis, prognosis, and treatment. This study assessed PET biomarker...

Full description

Bibliographic Details

Published in:	Annals of Clinical and Translational Neurology
Main Authors:	Cecilia Boccalini, Silvia Paola Caminiti, Arturo Chiti, Giovanni B. Frisoni, Valentina Garibotto, Daniela Perani, the Alzheimer's Disease Neuroimaging Initiative
Format:	Article
Language:	English
Published:	Wiley 2024-05-01
Online Access:	https://doi.org/10.1002/acn3.52039